Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

who presented the data at the World Conference on Lung cancer (WCLC). Dato-DXd is heading for a decision in December from the FDA based on the Tropion-Lung01 data, with the jury out on its ...